Peanut Hypersensitivity

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2022-11-23
EMA Application withdrawn: Abylqis (arachis hypogaea extract) — DBV Technologies
The EMA has withdrawn the application for Abylqis (arachis hypogaea extract) by DBV Technologies for peanut hypersensitivity.